Why is Symbiox Investme falling/rising?

As of 15-Sep, Symbiox Investment & Trading Co Ltd is currently priced at 2.84, reflecting a slight increase of 0.01 or 0.35%. The stock's performance today is in line with its sector, and it is trading above its 5-day, 20-day, and 50-day moving averages, although it remains below the 100-day and 200-day moving averages. Despite a recent return of -2.74% over the past year, the company has seen a 16% increase in profits, contributing to a PEG ratio of 0.1, indicating a fair valuation. However, the stock has experienced a decline in investor participation, with delivery volume falling by 9.59% against the 5-day average, which may indicate waning interest among investors.
In the broader market context, the stock has outperformed the benchmark Sensex over the past week and month, with returns of 1.43% and 9.65%, respectively, compared to the Sensex's 1.24% and 1.47%. However, year-to-date, the stock has significantly underperformed, with a decline of 47.60% against the Sensex's gain of 4.67%. This stark contrast highlights the challenges faced by Symbiox, including weak long-term fundamental strength, as evidenced by an average Return on Equity (ROE) of 0.77% and slow operating profit growth of 5.22% annually. These factors contribute to a cautious outlook for the stock despite its recent minor uptick.